Mark I. Greene
Director/Board Member at The Nightingale-Bamford School, Inc.
Profile
Mark I.
Greene is a trustee at The Nightingale-Bamford School, Inc. and a professor at Perelman School of Medicine.
He is also a member of the scientific advisory board at Macrophage Therapeutics, Inc. Previously, he served as chairman at The Allen-Stevenson School, director-emeritus at Emisphere Technologies, Inc., independent director at Navidea Biopharmaceuticals, Inc., and director at Ribi ImmunoChem Research, Inc. He was also an associate director at Abramson Cancer Center and an associate professor at Harvard University and Harvard Medical School.
Greene holds two doctorate degrees from the University of Manitoba.
Mark I. Greene active positions
| Companies | Position | Start |
|---|---|---|
Macrophage Therapeutics, Inc.
 Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Corporate Officer/Principal | - |
| Perelman School of Medicine | Corporate Officer/Principal | 01/01/1989 |
The Nightingale-Bamford School, Inc.
 The Nightingale-Bamford School, Inc. Other Consumer ServicesConsumer Services The Nightingale-Bamford School, Inc. operates as school. The company was founded in 1906 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of Mark I. Greene
| Companies | Position | End |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 14/08/2018 |
Abramson Cancer Center
 Abramson Cancer Center Hospital/Nursing ManagementHealth Services Part of University of Pennsylvania, Abramson Cancer Center operates cancer treatment centers. The private company is based in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2009 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1986 |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1986 |
The Allen-Stevenson School
 The Allen-Stevenson School Other Consumer ServicesConsumer Services The Allen-Stevenson School provides elementary education for boys. It provides pre-secondary program of academics, athletics, and the arts. The company was founded in 1883 and is headquartered in New York, NY. | Chairman | - |
Training of Mark I. Greene
| University of Manitoba | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
| Ribi ImmunoChem Research, Inc. | Health Technology |
The Allen-Stevenson School
The Allen-Stevenson School Other Consumer ServicesConsumer Services The Allen-Stevenson School provides elementary education for boys. It provides pre-secondary program of academics, athletics, and the arts. The company was founded in 1883 and is headquartered in New York, NY. | Consumer Services |
The Nightingale-Bamford School, Inc.
The Nightingale-Bamford School, Inc. Other Consumer ServicesConsumer Services The Nightingale-Bamford School, Inc. operates as school. The company was founded in 1906 and is headquartered in New York, NY. | Consumer Services |
Abramson Cancer Center
Abramson Cancer Center Hospital/Nursing ManagementHealth Services Part of University of Pennsylvania, Abramson Cancer Center operates cancer treatment centers. The private company is based in Philadelphia, PA. | Health Services |
Macrophage Therapeutics, Inc.
Macrophage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. develops immune-oncology and anti-inflammatory therapeutics. The CEO of the American company is Mike M. Goldberg. | Commercial Services |
- Stock Market
- Insiders
- Mark I. Greene
